We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Releases Final Guidance on Combination Drugs
FDA Releases Final Guidance on Combination Drugs
June 19, 2013
The FDA has released final guidance on codevelopment of two or more investigational drugs. Taking heed of industry comments, the document expands the definition of “codevelopment” and clarifies criteria for when codevelopment is an appropriate development option.